Drug intelligence / Profile preview

Amviacal

Development stage
Unknown
Lead developer
Amvia Biotech
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Oral
01

Overview

Amviacal is a multi-ingredient nutritional supplement developed by Amvia Biotech. It is formulated as an oral tablet containing a combination of calcium citrate (1000 mg), magnesium (100 mg), zinc (4 mg), and vitamin D3 (cholecalciferol, 200 IU). The supplement is primarily indicated for supporting bone health and addressing deficiencies in calcium and magnesium. Calcium citrate provides a highly bioavailable source of calcium for bone mineralization, while vitamin D3 enhances intestinal calcium absorption by acting as an agonist at the vitamin D receptor. Magnesium and zinc serve as essential cofactors in bone metabolism and various enzymatic processes.

Brand names
Amviacal
02

Targets

VDR (Vitamin D receptor)

Beyond the preview

Go deeper on Amviacal.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amviacal.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call